VPS41
Basic information
Region (hg38): 7:38722974-38932394
Links
Phenotypes
GenCC
Source:
- autosomal recessive cerebellar ataxia-saccadic intrusion syndrome (Supportive), mode of inheritance: AR
- spinocerebellar ataxia, autosomal recessive 29 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spinocerebellar ataxia, autosomal recessive 29 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 32808683; 33764426; 33851776 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VPS41 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 43 | 47 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 2 | 2 | 4 | |||
non coding | 39 | 39 | ||||
Total | 0 | 1 | 45 | 6 | 44 |
Variants in VPS41
This is a list of pathogenic ClinVar variants found in the VPS41 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-38726125-T-C | Benign (May 21, 2021) | |||
7-38726185-T-C | Benign (May 20, 2021) | |||
7-38726254-T-C | Inborn genetic diseases | Uncertain significance (Mar 11, 2022) | ||
7-38726256-A-G | Inborn genetic diseases | Uncertain significance (Feb 26, 2024) | ||
7-38726257-T-C | Inborn genetic diseases | Uncertain significance (Oct 10, 2023) | ||
7-38726273-T-TCCTGGTCCACGGTTCTTAGCACTG | Inborn genetic diseases | Benign (Mar 10, 2022) | ||
7-38726294-A-T | Inborn genetic diseases | Uncertain significance (Apr 25, 2023) | ||
7-38726316-G-A | Inborn genetic diseases | Uncertain significance (Nov 12, 2021) | ||
7-38726749-C-T | Benign (May 21, 2021) | |||
7-38726911-T-C | Inborn genetic diseases | Uncertain significance (Apr 16, 2024) | ||
7-38726954-A-G | Likely benign (Jun 01, 2023) | |||
7-38726968-C-T | Inborn genetic diseases | Likely benign (Oct 16, 2023) | ||
7-38726975-G-A | Likely benign (Jun 01, 2024) | |||
7-38726982-G-C | Inborn genetic diseases | Uncertain significance (Mar 17, 2023) | ||
7-38726993-C-A | Inborn genetic diseases | Uncertain significance (May 11, 2022) | ||
7-38727164-A-C | Benign (May 16, 2021) | |||
7-38728570-C-T | Likely benign (Nov 01, 2022) | |||
7-38728574-C-A | Spinocerebellar ataxia, autosomal recessive 29 | Pathogenic (Jul 06, 2021) | ||
7-38728575-A-G | Inborn genetic diseases | Uncertain significance (Dec 06, 2023) | ||
7-38728686-A-C | Uncertain significance (Sep 20, 2022) | |||
7-38728758-C-T | Inborn genetic diseases | Uncertain significance (Jul 19, 2022) | ||
7-38728781-C-T | Inborn genetic diseases | Uncertain significance (Jun 07, 2024) | ||
7-38742058-C-T | Inborn genetic diseases | Uncertain significance (Sep 06, 2022) | ||
7-38742222-C-T | Benign (May 16, 2021) | |||
7-38742250-T-C | Benign (May 20, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VPS41 | protein_coding | protein_coding | ENST00000310301 | 29 | 209432 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.42e-18 | 0.969 | 125522 | 0 | 224 | 125746 | 0.000891 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.48 | 358 | 446 | 0.803 | 0.0000223 | 5671 |
Missense in Polyphen | 98 | 133.02 | 0.73672 | 1673 | ||
Synonymous | -0.387 | 157 | 151 | 1.04 | 0.00000753 | 1459 |
Loss of Function | 2.55 | 37 | 57.9 | 0.639 | 0.00000312 | 712 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00113 | 0.00112 |
Ashkenazi Jewish | 0.00477 | 0.00477 |
East Asian | 0.00205 | 0.00196 |
Finnish | 0.000237 | 0.000231 |
European (Non-Finnish) | 0.000620 | 0.000615 |
Middle Eastern | 0.00205 | 0.00196 |
South Asian | 0.000797 | 0.000752 |
Other | 0.00164 | 0.00163 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in vesicle-mediated protein trafficking to lysosomal compartments including the endocytic membrane transport and autophagic pathways. Believed to act in part as a core component of the putative HOPS endosomal tethering complex is proposed to be involved in the Rab5-to-Rab7 endosome conversion probably implicating MON1A/B, and via binding SNAREs and SNARE complexes to mediate tethering and docking events during SNARE- mediated membrane fusion. The HOPS complex is proposed to be recruited to Rab7 on the late endosomal membrane and to regulate late endocytic, phagocytic and autophagic traffic towards lysosomes (PubMed:23351085). Involved in homotypic vesicle fusions between late endosomes and in heterotypic fusions between late endosomes and lysosomes implicated in degradation of endocytosed cargo (PubMed:9159129, PubMed:23167963, PubMed:25445562, PubMed:25908847). Required for fusion of autophagosomes with lysosomes (PubMed:25783203). May link the HOPS complex to endosomal Rab7 via its association with RILP and to lysosomal membranes via its association with ARL8B, suggesting that these interactions may bring the compartments to close proximity for fusion (PubMed:25445562, PubMed:25908847). Involved in the direct trans-Golgi network to late endosomes transport of lysosomal membrane proteins independently of HOPS (PubMed:23322049). Involved in sorting to the regulated secretory pathway presumably implicating the AP-3 adaptor complex (By similarity). May play a role in HOPS-independent function in the regulated secretory pathway (PubMed:24210660). {ECO:0000250|UniProtKB:D3ZVH6, ECO:0000269|PubMed:23167963, ECO:0000269|PubMed:23322049, ECO:0000269|PubMed:25445562, ECO:0000269|PubMed:25783203, ECO:0000269|PubMed:25908847, ECO:0000269|PubMed:9159129, ECO:0000305|PubMed:23167963, ECO:0000305|PubMed:23351085, ECO:0000305|PubMed:24210660, ECO:0000305|PubMed:25445562}.;
- Pathway
- Ebola Virus Pathway on Host;Ebola Virus Pathway on Host
(Consensus)
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- loftool
- 0.971
- rvis_EVS
- -0.33
- rvis_percentile_EVS
- 30.82
Haploinsufficiency Scores
- pHI
- 0.388
- hipred
- N
- hipred_score
- 0.488
- ghis
- 0.574
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.875
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Vps41
- Phenotype
- cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; embryo phenotype;
Gene ontology
- Biological process
- intracellular protein transport;autophagy;endosome to lysosome transport;endosomal vesicle fusion;regulation of SNARE complex assembly;vacuole fusion, non-autophagic;regulated exocytosis;late endosome to lysosome transport
- Cellular component
- lysosomal membrane;early endosome;late endosome;Golgi apparatus;Golgi-associated vesicle;endosome membrane;microtubule cytoskeleton;AP-3 adaptor complex;clathrin-coated vesicle;HOPS complex;late endosome membrane;clathrin complex
- Molecular function
- protein binding;microtubule binding;identical protein binding;protein self-association;metal ion binding